Format

Send to

Choose Destination
Int J Clin Exp Pathol. 2015 May 1;8(5):5363-70. eCollection 2015.

Amygdalin-mediated inhibition of non-small cell lung cancer cell invasion in vitro.

Author information

1
Department of Tumor Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.

Abstract

Lung cancer is a common malignant tumor claiming the highest fatality worldwide for a long period of time. Unfortunately, most of the current treatment methods are still based on the characteristics of cancer cells in the primary lesion and the prognosis is often much poorer in patients with metastatic cancers. Amygdalin, a natural product of glycosides and lots of evidence shows that amygdalin can inhibit the proliferation of some kinds of cancer cells. In this study, we first obtained the highly metastatic NSCLC cell lines H1299/M and PA/M and further treated these cells with amygdalin. We found that the in vitro proliferability of H1299/M and PA/M was inhibited, but such inhibition required higher concentration of amygdalin. When lower concentration of amygdalin was used for the experiments, we observed that the in vitro invasive and migration capacities of H1299/M and PA/M were significantly inhibited. These results strongly suggested that amygdalin was likely to have anti-metastatic NSCLC effect. This study offers information of the role of amygdalin that may be useful as a therapeutic target in lung tumors.

KEYWORDS:

Lung cancer; amygdalin; invasion

PMID:
26191238
PMCID:
PMC4503109
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center